Precision painkillers that are more accurate and less harmful to the liver are set to be developed by a University of Queensland spin-off company — potentially changing the lives of millions of people.
4 November 2022
A potential therapy targeting difficult-to-treat immune system disorders such as rheumatoid arthritis will progress to clinical trials next year after securing $20 million in Series A funding.
1 November 2019
The University of Queensland has received $24.5 million in the competitive Australian Research Council grants announced in Canberra today, securing a greater share of the pool than any other university.
6 May 2016
